Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
QNRX on Nasdaq
Dennis Langer - trading volume in the past year for Quoin Pharmaceuticals, Ltd.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| ADSs |
15,153 |
$128,648 |
$8.49 |
14 Oct 2025 |
Direct |
|
|
| Share Option (Right to Buy) |
21,709 |
|
|
04 Feb 2026 |
Direct |
ADS |
|
| Series H Warrants (Right to Buy) |
15,152 |
|
|
14 Oct 2025 |
Direct |
ADS |
|
| Series I Warrants (Right to Buy) |
15,152 |
|
|
14 Oct 2025 |
Direct |
ADS |
|
| Series J Warrants (Right to Buy) |
15,152 |
|
|
14 Oct 2025 |
Direct |
ADS |
|
| Series K Warrants (Right to Buy) |
15,152 |
|
|
14 Oct 2025 |
Direct |
ADS |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.